{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-028454","form_type":"8-K","ticker":"ACUT","cik":"0001850767","company_name":"Accustem Sciences Inc.","filed_at":"2022-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.739574+00:00","generated_at":"2026-06-23T03:38:07.609484+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AccuStem Sciences stockholders approve reverse stock split authorization at annual meeting","bullets":["Elected directors Wendy Blosser, Gabriele Cerrone, Willy Simon, John Brancaccio with >7M votes each.","Ratified Mazars USA LLP as independent auditor for fiscal year ending Dec 31, 2022.","Approved amendment to certificate of incorporation to effect reverse stock split (1:2 to 1:15) before Oct 10, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-028454","json":"https://secwatch.observer/filing/0001493152-22-028454.json","markdown":"https://secwatch.observer/filing/0001493152-22-028454.md","text":"https://secwatch.observer/filing/0001493152-22-028454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222028454/0001493152-22-028454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850767/000149315222028454/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T03:38:07.609484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}